Publication date: Aug 11, 2026
This multicenter, observational, retrospective-prospective study aims to evaluate the prevalence and trajectory of Post-Acute Sequelae of COVID-19 (PASC) approximately 5 years after SARS-CoV-2 infection. The study will re-contact participants from an established cohort of more than 3,000 individuals with microbiologically confirmed SARS-CoV-2 infection, including both hospitalized and non-hospitalized patients, previously followed in dedicated post-COVID outpatient clinics. Participants will undergo a structured telephone interview approximately 60 +/- 3 months after infection, and those meeting predefined clinical criteria will be invited to an in-person clinical assessment. The study will evaluate persistent symptoms, functional status, cognitive and nutritional status, frailty, sarcopenia, quality of life, healthcare resource utilization, and direct and indirect healthcare costs to characterize the long-term trajectory of PASC.
| Concepts | Keywords |
|---|---|
| Acute | |
| Clinical | |
| Cohort | |
| Cov | |
| Covid | |
| Criteria | |
| Follow | |
| Infection | |
| Informed | |
| Months | |
| Participants | |
| Pasc | |
| Post | |
| Prevalence | |
| Sars |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Sars-CoV-2 Infection |
| pathway | REACTOME | SARS-CoV-2 Infection |
| disease | MESH | Post-Acute Sequelae of COVID-19 |
| disease | MESH | infection |
| disease | MESH | frailty |
| disease | MESH | sarcopenia |